CLINICAL_TRIALS
trial_result
· 2024-01-10
Clinical Trial Update: Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN [Phase 2]
Summary
Phase 2 trial results evaluate whether adding focused high-dose radiation to PD-1–directed therapy can overcome resistance in head and neck cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Head and Neck Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-01-10